Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
37 hedge funds and large institutions have $4.59M invested in Acer Therapeutics Inc in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 4 closing their positions.
8% less funds holding
Funds holding: 40 → 37 (-3)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
53% less capital invested
Capital invested by funds: $9.73M → $4.59M (-$5.13M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$92.2K |
| 2 |
State Street
Boston,
Massachusetts
|
+$92.2K |
| 3 |
Bank of New York Mellon
New York
|
+$39.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$36.9K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$6.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$295K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$95.3K |
| 3 |
Two Sigma Investments
New York
|
-$84K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$80K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$51.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCA
26
Berman Capital Advisors
Atlanta,
Georgia
| $5K | – | – | – |
|
27
Citigroup
New York
| $4K | +$1.73K | +471 | +35% |
|
|
28
Victory Capital Management
San Antonio,
Texas
| $4K | +$6.54K | +1,784 | New |
|
29
BNP Paribas Financial Markets
Paris,
France
| $3.09K | +$3.12K | +851 | +122% |
|
30
Legal & General Group
London,
United Kingdom
| $3K | +$4.54K | +1,238 | +652% |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $2K | +$590 | +161 | +15% |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$2.81K | +768 | +277% |
|
|
MAM
33
Meeder Asset Management
Dublin,
Ohio
| $1K | -$3.21K | -876 | -57% |
|
|
AIP
34
Ameritas Investment Partners
Lincoln,
Nebraska
| $1K | – | – | – |
|
|
JGC
35
J. Goldman & Co
New York
| – | -$295K | -73,510 | Closed |
|
|
36
Two Sigma Investments
New York
| – | -$84K | -21,042 | Closed |
|
|
SCM
37
Stonepine Capital Management
Bend,
Oregon
| – | -$80K | -20,000 | Closed |
|
|
OSAM
38
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$14K | -3,593 | Closed |
|
39
Bank of America
Charlotte,
North Carolina
| – | -$1.78K | -487 | -76% |
|
ACER Hedge Fund Activity: Q1 2020 in Review
37 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2020, worth a combined $4.59M — down 53% from $9.73M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ACER and 1 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Federated Hermes, adding an estimated $92.2K. The largest seller was J. Goldman & Co, exiting entirely with an estimated $295K sold.
- 37 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2020, down from 40 in Q4 2019.
- Funds reported $4.59M of Acer Therapeutics Inc stock for Q1 2020, down 53% quarter-over-quarter.
- 1 fund opened new Acer Therapeutics Inc positions in Q1 2020 and 4 closed out, a net change of -3 holders.
- The largest Acer Therapeutics Inc buyer in Q1 2020 was Federated Hermes, an estimated $92.2K added.
- The largest Acer Therapeutics Inc seller in Q1 2020 was J. Goldman & Co, an estimated $295K sold.
Based on aggregated 13F filings for Q1 2020.